Prelude Therapeutics Inc

PRLD Nasdaq SEC CIK 1678660

Follow Prelude Therapeutics Weekly email: filings, results, news

News

1 story filed under Prelude Therapeutics

Markets 32 d ago

NOV10

Q3 2026 results

Tuesday · estimated from the filing cadence

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 1 story clustered from the RSS aggregator